PPT-Pharmacovigilance: New challenges for WHO

Dr Shanthi Pal Group Lead Medicines Safety DirectorEMP K De Joncheere Coordinator PAU G Forte HeadRHT LRago CoordinatorPHI M Zafar Coordinator PQT Coordinator RSS N Dellepiane. 41 Ellesmere Po New New Hig New Eas New 15 mins 30 mins 15 mins 30 mins 60 mins 30 mins 20 mins 10 mins 30 mins 218219 30 mins 15 mins 30 mins 15 mins 30 mins 60 mins 30 mins 20 mins 20 mins 30 mins Ver. 10.31.12. . . 1) . Pre-questions. 2. ) . Line Following Challenge . – 6 slides. 3) . Jousting Challenge. – 4 slides. Fire Fighting Challenge. – 3 slides. Robotovate® Challenge. – 2 slides. New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. . Mr . Alecos. Michaelides. Permanent Secretary. Ministry of Transport, Communications and Works. Cyprus Shipping: New Challenges and Prospects. JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepidemiology. Pharmacovigilance. JAMASOFT2017. 2. P. armacovigilance. system collects data . throughout the . lifecycle . of each . medicinal. . product. , MD. Pfizer, India. DISCLAIMER. Overview. Introduction & Terminology. Why Pharmacovigilance?. Pharmacovigilance Practices. : International & Indian. PVPI. Drug Safety Issues in Clinical Trials . Shanthi Pal. Leader, Medicines Safety. Safety . and Vigilance,. WHO, Geneva. What is pharmacovigilance. The science and activities relating to the detection, assessment, understanding and prevention of . at national . and EU level. Susanna Palkonen, Director . susanna.palkonen. @efanet.org. . European Federation of Allergy and Airways Diseases Patients’ Associations (EFA). Who is EFA?. The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA). & . Adverse Drug Reactions . Reporting systems. Dr. . Habab. Khalid . Elkheir. B.Pharm. ., . M.Pharm. ., PhD . ISOP. ISPE. IUATLD. SSCP. 11/28/2017. Habab khalid Elkheir. Objectives of the workshop. . SYFTET. Göteborgs universitet ska skapa en modern, lättanvänd och . effektiv webbmiljö med fokus på användarnas förväntningar.. 1. ETT UNIVERSITET – EN GEMENSAM WEBB. Innehåll som är intressant för de prioriterade målgrupperna samlas på ett ställe till exempel:. 1466 Nikhil GuptaKavita BahmaniAjit Jangra IntroductionPharmacovigilance and drug safety remains As per the World Health Organization (WHO), Pharmacovigilance may be dened ClinicalPractice ISSN No medicine is without . risk and the.  . benefits of . a medicine must always be weighed up against its risks. . The . balance of benefits and risks should be effectively considered and must not be left to chance. Definition- . According to the CIOMS/WHO working group on vaccine pharmacovigilance, . Vaccine . pharmacovigilance is defined as “the science and activities relating to the” . . o . Detection, . Authors: . 1. Juliet Jokwiro, . 1. Nicole Chekudambune-Kawaza, . 1. Kenny Sithole, . 1. Bongani Dube, . 2. Charles Sandy, . 2. Manners Ncube, . 2 . Regina Mubau,. 2. Chlorata Gwanzura, . 2. Kwenziweyinkosi Ndlovu, .